In line with these findings, intracerebroventricular infusion of Ang-(1-7) over 6 weeks in stroke-prone SHR, an established animal model of hypertension-induced hemorrhagic stroke, increased survival time and improved neurological status [49]. The gene discussed is ANG; the disease is hypertensive disorder.